A second immunotherapy approach consists of tumor extirpation to infiltrate it later with Th1 cells and IL-15, IL-18, and IFN-α cytokines and subsequently reimplant the tumor-tissue into the patient, in a subcutaneous region closer to some lymph nodes intraperitoneal. Here, IL18 is linked to neoplasm.